The Ultra Study
ULTRA is a study of a new, FDA approved fibroid treatment called radiofrequency ablation. This procedure uses heat to destroy fibroid tissue during a laparoscopic surgery. Women return home on the day of the procedure and are back to their normal activities in 5-9 days. The goal of the study is to evaluate how fibroid symptoms change over time after radiofrequency ablation. If you participate in the ULTRA study, you will receive Radiofrequency Ablation and complete questionnaires about your fibroid symptoms and reproductive health. You may be eligible to participate in the study if you:
1. Are at least 21 years of age
2. Have uterine fibroids that cause heavy bleeding, pelvic pressure or discomfort, urinary or bowel symptoms, or dyspareunia (painful sexual intercourse)
3. Have fibroids ≤10cm in maximum diameter
4. Are able to undergo laparoscopic surgery
You can read more about the ULTRA study at http://clinicaltrials.gov/show/NCT01840124.
If you are interested in participating in ULTRA, please contact the study coordinator, Sarah Steimer. Contact number: (916) 734-6846&Email: email@example.com